Twist Bioscience Corporation

NasdaqGS:TWST 주식 보고서

시가총액: US$2.9b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Twist Bioscience 관리

관리 기준 확인 3/4

Twist Bioscience's CEO는 Emily Leproust, Apr2013 에 임명되었습니다 의 임기는 11.17 년입니다. 총 연간 보상은 $ 8.00M, 8.6% 로 구성됩니다. 8.6% 급여 및 91.4% 보너스(회사 주식 및 옵션 포함). 는 $ 10.98M 가치에 해당하는 회사 주식의 0.37% 직접 소유합니다. 10.98M. 경영진과 이사회의 평균 재임 기간은 각각 3 년과 7.6 년입니다.

주요 정보

Emily Leproust

최고 경영자

US$8.0m

총 보상

CEO 급여 비율8.6%
CEO 임기11.2yrs
CEO 소유권0.4%
경영진 평균 재임 기간3yrs
이사회 평균 재임 기간7.6yrs

최근 관리 업데이트

Here's Why Shareholders May Want To Be Cautious With Increasing Twist Bioscience Corporation's (NASDAQ:TWST) CEO Pay Packet

Jan 31
Here's Why Shareholders May Want To Be Cautious With Increasing Twist Bioscience Corporation's (NASDAQ:TWST) CEO Pay Packet

Recent updates

We Think Twist Bioscience (NASDAQ:TWST) Can Easily Afford To Drive Business Growth

Jun 10
We Think Twist Bioscience (NASDAQ:TWST) Can Easily Afford To Drive Business Growth

Twist Bioscience Corporation (NASDAQ:TWST) Shares Fly 29% But Investors Aren't Buying For Growth

May 04
Twist Bioscience Corporation (NASDAQ:TWST) Shares Fly 29% But Investors Aren't Buying For Growth

Twist Bioscience: NGS Is Taking Off

May 03

Twist Bioscience Corporation (NASDAQ:TWST) Surges 26% Yet Its Low P/S Is No Reason For Excitement

Feb 27
Twist Bioscience Corporation (NASDAQ:TWST) Surges 26% Yet Its Low P/S Is No Reason For Excitement

Twist Bioscience: Strong Performance In A Soft Market

Feb 07

Here's Why Shareholders May Want To Be Cautious With Increasing Twist Bioscience Corporation's (NASDAQ:TWST) CEO Pay Packet

Jan 31
Here's Why Shareholders May Want To Be Cautious With Increasing Twist Bioscience Corporation's (NASDAQ:TWST) CEO Pay Packet

We're Not Very Worried About Twist Bioscience's (NASDAQ:TWST) Cash Burn Rate

Jan 22
We're Not Very Worried About Twist Bioscience's (NASDAQ:TWST) Cash Burn Rate

Twist Bioscience Corporation's (NASDAQ:TWST) Price Is Right But Growth Is Lacking After Shares Rocket 44%

Dec 18
Twist Bioscience Corporation's (NASDAQ:TWST) Price Is Right But Growth Is Lacking After Shares Rocket 44%

Twist Bioscience (NASDAQ:TWST) Is In A Good Position To Deliver On Growth Plans

Oct 05
Twist Bioscience (NASDAQ:TWST) Is In A Good Position To Deliver On Growth Plans

We Think Twist Bioscience (NASDAQ:TWST) Can Afford To Drive Business Growth

Jul 07
We Think Twist Bioscience (NASDAQ:TWST) Can Afford To Drive Business Growth

Twist Biosciences collaborates with Enzolytics on monoclonal antibodies for viruses

Sep 16

Twist Bioscience: DNA Synthesis Leader Appealing 'Picks And Shovels' Play

Sep 02

Twist Bioscience: DNA Synthesis Leader Is Just Getting Started

Aug 08

Twist Bioscience/ Biotia sequencing assay granted FDA nod to detect COVID variants

Aug 02

Twist Biosciences to work with DNAnexus on sequencing-based diagnostic tests

Jul 13

Twist Bioscience, Ildong team up to discover antibodies for cancer therapies

Jun 30

Twist Bioscience: A First Take

May 26

CEO 보상 분석

Emily Leproust 의 보수는 Twist Bioscience 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Mar 31 2024n/an/a

-US$192m

Dec 31 2023n/an/a

-US$206m

Sep 30 2023US$8mUS$685k

-US$205m

Jun 30 2023n/an/a

-US$209m

Mar 31 2023n/an/a

-US$213m

Dec 31 2022n/an/a

-US$214m

Sep 30 2022US$6mUS$665k

-US$218m

Jun 30 2022n/an/a

-US$208m

Mar 31 2022n/an/a

-US$188m

Dec 31 2021n/an/a

-US$165m

Sep 30 2021US$1mUS$590k

-US$152m

Jun 30 2021n/an/a

-US$135m

Mar 31 2021n/an/a

-US$123m

Dec 31 2020n/an/a

-US$117m

Sep 30 2020US$7mUS$519k

-US$140m

Jun 30 2020n/an/a

-US$147m

Mar 31 2020n/an/a

-US$147m

Dec 31 2019n/an/a

-US$141m

Sep 30 2019US$8mUS$477k

-US$108m

Jun 30 2019n/an/a

-US$96m

Mar 31 2019n/an/a

-US$86m

Dec 31 2018n/an/a

-US$77m

Sep 30 2018US$525kUS$362k

-US$71m

Jun 30 2018n/an/a

-US$68m

Sep 30 2017US$2mUS$340k

-US$59m

보상 대 시장: Emily 의 총 보상 ($USD 8.00M )은 US 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 6.80M ).

보상과 수익: 회사가 수익성이 없는 동안 Emily 의 보상이 증가했습니다.

CEO

Emily Leproust (51 yo)

11.2yrs

테뉴어

US$7,998,637

보상

Dr. Emily Marine Leproust, Ph.D. serves as Independent Director at CM Life Sciences, Inc. since September 2, 2020. She serves as an Independent Director at GeneDx Holdings Corp. (formerly known as Sema4 Ho...

리더십 팀

이름위치테뉴어보상소유권
Emily Leproust
Co-Founder11.2yrsUS$8.00m0.38%
$ 10.8m
Patrick Finn
President & COO1.7yrsUS$5.23m0.078%
$ 2.2m
Paula Green
Senior Vice President of Human Resources8.3yrsUS$2.49m0.034%
$ 986.5k
William Banyai
Senior VP of Advanced Development4.4yrsUS$2.82m0.44%
$ 12.7m
Adam Laponis
Chief Financial Officerless than a year데이터 없음0.0017%
$ 49.6k
Robert Werner
VP & Chief Accounting Officer1.1yrs데이터 없음0.0096%
$ 276.3k
Siyuan Chen
Chief Technology Officer3.3yrs데이터 없음데이터 없음
Aaron Sato
Chief Scientific Officer3.3yrs데이터 없음데이터 없음
Chet Gandhi
Chief Information Officerless than a year데이터 없음데이터 없음
Dennis Cho
Senior VP2.8yrsUS$1.96m0.045%
$ 1.3m
Angela Bitting
Chief ESG Officer & Senior VP of Corporate Affairs3.3yrs데이터 없음데이터 없음
Mark Buck
Senior Vice President of Operationsless than a year데이터 없음데이터 없음

3.0yrs

평균 재임 기간

52yo

평균 연령

경험이 풍부한 관리: TWST 의 관리팀은 경험 ( 3 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
Emily Leproust
Co-Founder11.2yrsUS$8.00m0.38%
$ 10.8m
William Banyai
Senior VP of Advanced Development11.2yrsUS$2.82m0.44%
$ 12.7m
Keith Crandell
Independent Director10.7yrsUS$272.49k0.16%
$ 4.6m
Robert Chess
Lead Independent Director9.9yrsUS$303.98k0.11%
$ 3.2m
Nelson Chan
Independent Director5.1yrsUS$284.99k0.031%
$ 880.6k
Robert Ragusa
Independent Director7.6yrsUS$271.34k0.023%
$ 670.3k
Jan Johannessen
Independent Director5.7yrsUS$284.99k0.020%
$ 572.4k
Melissa Starovasnik
Independent Director2.8yrsUS$276.61k0.019%
$ 536.3k
Xiaoying Mai
Independent Director5.9yrsUS$269.99k0.043%
$ 1.2m

7.6yrs

평균 재임 기간

64yo

평균 연령

경험이 풍부한 이사회: TWST 의 이사회는 경험(평균 재직 기간 7.6 년)으로 간주됩니다.